Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

JAN 02, 2013 - Benzinga

A Must Read - Share

Cantor Fitzgerald Reiterates Buy Rating, $60 PT on Salix Pharmaceuticals Ltd.

In a report published Wednesday, Cantor Fitzgerald reiterated its Buy rating and $60.00 price target on Salix Pharmaceuticals Ltd. (NASDAQ: SLXP). Cantor Fitzgerald noted, “Management has previously guided to a $150-200M opportunity for this product.

Tags: Cantor Fitzgerald Reiterates Buy Rating, $60 PT on Salix Pharmaceuticals Ltd.,  Cantor Fitzgerald Latest News